News
Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.
Five NY research centers form Empire State Cellular Therapy Consortium to accelerate cell therapy access for patients.
The Fulham midfielder talks freedom on and off the pitch, and a blossoming career that is approaching 300 Premier League appearances ...
The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...
Dr. Jitendra Singh inaugurates India's first National Biobank and Longitudinal Population Study at CSIR-IGIB to boost genomic ...
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
This year’s theme, “A Sickle Cell Family Reunion,” honors the tight-knit community of patients, caregivers, clinicians, researchers, and advocates who have turned pain into purpose and forged ...
NIH cancels research grant for disease that affects mostly Black patients, citing DEI, doctor says 90% of Sickle cell disease patients are Black, according to NIH ...
Sickle cell disease (SCD) is a group of disorders that affects haemoglobin, which causes distorted sickle- or crescent-shaped red blood cells. It is characterized by anaemia, increased susceptibility ...
Learn about the clinical and pathological features of stroke in individuals with sickle cell disease and strategies for prevention and management of stroke in this patient population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results